- Report
- January 2026
- 180 Pages
Global
From €3450EUR$3,939USD£2,994GBP
- Report
- January 2026
- 199 Pages
Global
From €3450EUR$3,939USD£2,994GBP
- Report
- November 2025
- 196 Pages
Global
From €3450EUR$3,939USD£2,994GBP
- Report
- August 2025
- 182 Pages
Global
From €3450EUR$3,939USD£2,994GBP
- Report
- February 2026
- 378 Pages
Global
From €5124EUR$5,850USD£4,447GBP
- Report
- August 2025
- 188 Pages
Global
From €3450EUR$3,939USD£2,994GBP
- Report
- August 2025
- 189 Pages
Global
From €3450EUR$3,939USD£2,994GBP
- Report
- September 2025
- 250 Pages
Global
From €3932EUR$4,490USD£3,413GBP
- Clinical Trials
- July 2025
- 80 Pages
Global
From €1752EUR$2,000USD£1,520GBP
- Clinical Trials
- July 2025
- 60 Pages
Global
From €1095EUR$1,250USD£950GBP
- Clinical Trials
- April 2025
- 80 Pages
Global
From €1752EUR$2,000USD£1,520GBP
- Clinical Trials
- April 2025
- 80 Pages
Global
From €1752EUR$2,000USD£1,520GBP
- Report
- October 2025
- 250 Pages
Global
From €3932EUR$4,490USD£3,413GBP
- Report
- May 2025
- 169 Pages
Global
From €4160EUR$4,750USD£3,611GBP
- Report
- June 2025
- 200 Pages
Global
From €2443EUR$2,789USD£2,120GBP
- Newsletter
- February 2026
Global
€2623EUR$2,995USD£2,277GBP
- Report
- April 2022
- 400 Pages
Global
€1533EUR$1,750USD£1,330GBP
- Report
- October 2024
- 160 Pages
Global
From €6963EUR$7,950USD£6,043GBP
- Report
- May 2024
- 133 Pages
Global
From €3502EUR$3,999USD£3,040GBP
- Report
- May 2024
- 134 Pages
Global
From €3502EUR$3,999USD£3,040GBP

Edema is a medical condition characterized by the accumulation of fluid in the body's tissues. It is a common symptom of many diseases and can be caused by a variety of factors, including trauma, infection, and inflammation. In the biotechnology market, edema is a major area of research and development, with a focus on developing treatments and therapies to reduce the symptoms and improve the quality of life of those affected.
The biotechnology market for edema is highly competitive, with a range of companies developing treatments and therapies to address the condition. These include pharmaceutical companies, biotechnology companies, and medical device companies. Examples of companies in this market include AbbVie, Amgen, AstraZeneca, Biogen, and Novartis. Show Less Read more